Medindia
Medindia LOGIN REGISTER
Advertisement

HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes

Tuesday, October 23, 2007 General News
Advertisement
NEW YORK, Oct. 22 HealthShares(TM) Inc., an investmentcompany with a series of 20 underlying fund portfolios, today announced it hasbeen informed by Standard & Poor's, the calculating agent for theHealthShares(TM) Indexes, that effective at the opening of trading on ThursdayOctober 25, 2007, Amag Pharmaceuticals (Nasdaq: AMAG) will replace Cytyc Corp.(Nasdaq: CYTC) in the HealthShares(TM) Diagnostics Index, and Hologic Inc.(Nasdaq: HOLX) will replace Cytyc Corp in the HealthShares(TM) CompositeIndex. Cytyc Corp. is being acquired by Hologic Inc. Companies included in theHealthShares(TM) Diagnostics Index are engaged in the identification of theexistence and extent of a disease, the visual localization of a disease by wayof imaging, the selection of therapeutic agents appropriate for the diseasewherever possible and the monitoring of disease progression/therapeuticefficacy.
Advertisement

About HealthShares(TM)

XShares Advisors LLC, a financial services company based in New York, isthe creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs).HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and representspecific areas of the healthcare, life science and biotechnology industries.Each Vertical addresses a distinct sub-segment of healthcare, such as thediagnosis and treatment of specific therapeutic areas (e.g. cardiology,cancer, infectious disease, etc.) and the development of medical devices (e.g.orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22stocks, except the Composite which tracks 80 stocks, and offers institutionaland individual investors a more precise financial instrument that leveragesthe potential of healthcare investing while mitigating the risks of singlestock picking. For more information, visit the websitewww.healthsharesinc.com.
Advertisement

About XShares

XShares Advisors LLC, a subsidiary of XShares Group LLC, is a registeredinvestment advisor that provides investment advisory services to ExchangeTraded Funds. XShares also partners with major institutions and indexproviders seeking to bring innovative Exchange Traded Funds to market usingits administrative platform. In addition, XShares creates and licensesdistinctive intellectual property for its ETFs, developing products that allowfor innovative trading strategies and alternative investments for thefinancial community. For more information, visit the websitewww.xsharesadvisors.com.

An Investor should consider the fund's investment objective, risks,charges and expenses carefully before investing. For this and more completeinformation about the fund call 800.925.2870 or visit the websitewww.healthsharesinc.com for a prospectus. Please read the prospectus carefullybefore investing.

There are risks involved with investing in ETFs including possible loss ofmoney. HealthShares(TM) are not actively managed and are subject to riskssimilar to stocks, including those related to short selling and marginmaintenance. Losses from short sales may be unlimited, and losses frompurchases on margin may exceed original investment. Normal brokeragecommissions apply. HealthShares(TM) ETFs are subject to increased risksassociated with investing in a specific sector compared to a more diversifiedinvestment, as well as unique risks associated with the healthcare andbiotechnology sector (i.e., government regulation, patent regulation, etc.).

The ETFs face additional risks attributable to their investments in smalland medium capitalization companies which are subject to higher volatilitythan larger, more established companies. In addition, they are invested in alimited number of securities and a decline in the value of these investmentswould cause the fund's overall value to decline to a greater degree than in aless concentrated portfolio.

Global or International Funds invest in foreign securities that will besubject to certain risks n
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close